Essex Investment Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Essex Investment Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-364,401	Closed	-$988K	–	545
2018 Q3	$988K	Buy	364,401 +199,796	+121%	+$413K	0.12%	232
2018 Q2	$314K	Buy	+164,605	New	+$333K	0.04%	332
2015 Q1	–	Sell	-19,863	Closed	-$335K	–	356
2014 Q4	$335K	Sell	19,863 -5,653	-22%	-$82.3K	0.05%	268
2014 Q3	$342K	Buy	+25,516	New	+$304K	0.05%	276

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Essex Investment Management's INFI Position: Q4 2018 in Review

Essex Investment Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2018, closing a stake of 364,401 shares — an estimated $988K sold.

Essex Investment Management first reported a position in INFI in Q3 2014 and held it in 4 quarters. The position peaked at $988K in Q3 2018. 64 funds tracked by Wall St. Rank hold INFI as of Q4 2018.

Essex Investment Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
Essex Investment Management sold 364,401 Infinity Pharmaceuticals, Inc. shares in Q4 2018, an estimated $988K.
Essex Investment Management first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2014 and held it in 4 quarters.
Essex Investment Management's Infinity Pharmaceuticals, Inc. position peaked at $988K in Q3 2018.
64 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2018.

Based on Essex Investment Management's 13F filing for Q4 2018, filed 6 Feb 2019.